查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1993146

动脉舌封堵器市场：依封堵机制、材料、最终用途、应用及通路划分－2026-2032年全球市场预测

Arteriotomy Closure Devices Market by Closure Mechanism, Material, End Use, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，动脉闭合装置市场价值将达到 14.3 亿美元，到 2026 年将成长至 15.2 亿美元，到 2032 年将达到 22.6 亿美元，复合年增长率为 6.78%。

主要市场统计数据
基准年 2025 14.3亿美元
预计年份：2026年 15.2亿美元
预测年份 2032 22.6亿美元
复合年增长率 (%) 6.78%

对动脉扭转闭合装置市场进行简要概述，提供影响策略决策的临床、供应链和商业性因素概述。

动脉闭合器械市场处于介入性心臟病学、週边血管介入和介入放射学的交汇点，手术效率和病人安全是医院和门诊采购及临床路径制定的基础。器械设计、材料科学和手术流程的创新改变了临床医生的选择偏好。同时，支付方的严格审查和基于价值的医疗模式提高了对治疗效果和后续医疗成本改善的显着要求。本执行摘要整合了近期临床、监管和商业性方面的最新进展，旨在为决策者制定资本计划、产品开发和打入市场策略提供切实可行的见解。

技术、流程和供应链的重大变革正在重塑医疗设备选择的临床引入、采购重点和竞争差异化。

过去几年，动脉闭合领域经历了变革性的转变，这主要得益于技术、手术流程和治疗模式的同步发展。器械技术已从传统的缝合系统发展到日益多样化的组合式系统，这些系统强调快速止血、缩短下床活动时间以及与经皮大直径入路的兼容性。与器械创新相辅相成的是，临床医生正在采用手术流程标准化和影像引导技术来减少治疗结果的差异，这正在影响医院的器械采纳曲线和采购优先顺序。

关税引起的成本压力和供应链中断对采购决策、定价趋势和策略采购重点的影响（截至 2025 年）。

2025年，美国实施或调整的关税措施的累积影响将波及动脉切开和闭合器械的整个价值链，对零件采购、生产计画和定价策略产生显着影响。关税压力加剧了依赖进口原材料和零件的製造商的成本敏感性，进而影响其库存缓衝和供应商多元化决策。为此，一些製造商正在加快本地化进程，并与供应商重新谈判合同，以降低关税波动和海关延误带来的风险。

从综合细分的观点，将机制、临床环境、材料成分和分销管道与推动采用和商业化的因素联繫起来。

详细的市场区隔分析揭示了器材设计、临床环境和材料选择如何相互交织，共同塑造产品上市模式和市场进入策略。根据闭合机制，市场可细分为夹式系统、塞式解决方案、密封剂产品和缝合式器械。夹式系统可细分为金属夹和聚合物夹，塞式解决方案可细分为胶原蛋白塞和各种聚合物塞，缝合式产品则可细分为可吸收和不可吸收两种类型。这些机制上的差异会影响临床医生的选择，因为他们需要在易用性、器械形状和对特定入路尺寸的适用性之间取得平衡，同时也决定了产品的製造复杂性和监管核准流程。

支付方行为、监管复杂性以及程序采用的细微区域差异，决定了差异化的商业化和证据产生策略。

区域趋势持续对产品开发重点、监管策略和商业计划产生重大影响。在美洲，医疗系统优先考虑能够提高效率并支援当天出院的技术，而支付方则越来越关注治疗结果和打包支付模式。这促使那些能够缩短住院时间并显着降低併发症发生率的医疗器材被推广。在欧洲、中东和非洲，法规结构的多样性和不同的报销环境通常需要针对多个地区制定证据包和适应性定价策略才能进入市场。同时，欧洲主要市场的领先医疗中心推动了临床应用，这种趋势随后会辐射到邻近的医疗系统。

竞争格局正在向强调证据生成、有针对性的伙伴关係和综合服务模式的方向转变，以促进差异化和推广应用。

动脉闭合领域的竞争格局呈现出多元化的特点，既有成熟的医疗设备製造商，也有专注于特定领域的专业製造商，以及利用新型材料和简化导入技术的新兴参与企业。主要企业正优先进行临床证据的收集、完善的上市后监测以及临床医生培训项目，以降低治疗结果的差异性，并加速在高频医疗机构中的应用。该市场普遍采取的策略性措施包括：透过有针对性的收购来拓展产品系列；与契约製造製造商合作以快速提升产能；以及投资收集和分析真实世界临床数据，以便与监管机构和保险公司进行沟通。

企业应采取具有重大影响力的营运、临床证据和商业倡议，以加强其市场地位并加速推广应用。

产业领导企业应透过一系列协调一致的倡议，整合产品、临床和商业策略，从而建立强大的竞争优势。首先，他们应优先开发和传播可靠的真实世界证据和以临床医生主导的疗效研究，将设备性能与可衡量的改进（例如提高患者容量和减少併发症）联繫起来。其次，他们应重新设计供应链，透过认证替代供应商，并在可能的情况下探索区域製造方案，以降低关税波动和单一来源风险的影响。第三，他们应针对特定临床环境，建立量身定制的市场进入模式，为门诊手术中心、导管检查室和医院系统提供有针对性的培训和支持，确保每个管道都能获得适当的部署支援和部署后跟进。

采用严谨的混合方法研究途径，结合临床医师访谈、文献回顾和使用真实世界资料的检验，以检验策略见解。

本分析整合了初级和次级研究方法，以确保研究结果在临床、商业性和监管层面检验。初级资料包括对介入性心臟病专家、血管外科医师、介入性放射科医师、采购经理和产品经理的结构化访谈，并辅以专注于医疗设备选择标准和手术流程的临床医生问卷。次级研究纳入了同行评审的临床文献、监管文件和专业学会发布的指南，以提供关于医疗设备性能和安全性的论点的背景资讯。数据三角测量技术用于校正资讯来源之间的差异并突出一致的主题。

强调证据一致性、供应链韧性和有针对性的商业化的策略整合是实现永续竞争优势的关键要素。

总而言之，动脉闭合器材的市场格局正日趋成熟，各种解决方案在提供可证实的临床获益的同时，也不断适应不断变化的医疗服务和报销模式。技术创新、手术向门诊转移以及关税趋势带来的供应链压力，共同影响产品的选择和商业化策略。那些能够将实证实践与营运价值提案结合，并着力提升供应链韧性的相关人员，将更有能力影响采购决策和临床路径。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依闭合机制分類的动脉舌闭合装置市场

  • 夹子类型
    • 金属夹
    • 聚合物夹
  • 插头类型
    • 胶原蛋白塞
    • 聚合物塞
  • 密封剂类型
  • 缝合基部
    • 吸收性
    • 不吸收

第九章：动脉舌封堵器市场：依材料分类

  • 胶原蛋白
  • 金属
  • 聚合物

第十章：动脉舌封堵器市场：依最终用途划分

  • 门诊手术中心
  • 心臟导管检查室
  • 医院
    • 私立医院
    • 公立医院

第十一章：动脉舌闭合装置市场：依应用领域划分

  • 循环系统
  • 週边血管
  • 放射科

第十二章：动脉舌封堵器市场：依通路划分

  • 直销
  • 销售代理
  • 线上供应商

第十三章：动脉舌封堵器市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：动脉舌闭合装置市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：动脉舌封堵器市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国动脉造口闭合装置市场

第十七章：中国动脉切割和闭合器械市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Aesculap, Inc.
  • Arstasis, Inc.
  • Artivion, Inc.
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CytoSorbents Corporation
  • Fumedica AG
  • Humacyte Global Inc.
  • iVascular, SLU
  • IVT Medical Ltd.
  • KOAG LLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • Mitralign Inc.
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • TOTAL Vein Solutions, LLC
  • Transluminal Technologies Inc.
  • Tricol Biomedical Inc.
  • Vasorum Ltd.
Product Code: MRR-1A1A064C02DB

The Arteriotomy Closure Devices Market was valued at USD 1.43 billion in 2025 and is projected to grow to USD 1.52 billion in 2026, with a CAGR of 6.78%, reaching USD 2.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.43 billion
Estimated Year [2026] USD 1.52 billion
Forecast Year [2032] USD 2.26 billion
CAGR (%) 6.78%

A concise orientation to the arteriotomy closure device environment that frames clinical, supply chain, and commercial forces shaping strategic decision-making

The arteriotomy closure device space sits at the intersection of interventional cardiology, peripheral vascular intervention, and interventional radiology, with procedural efficiency and patient safety shaping procurement and clinical pathways across hospitals and ambulatory settings. Innovations in device design, material science, and procedural workflows have altered operator preferences, while payer scrutiny and value-based care models are raising the bar for demonstrable improvements in outcomes and downstream cost of care. This executive summary synthesizes recent clinical, regulatory, and commercial dynamics to equip decision-makers with pragmatic intelligence for capital planning, product development, and market access strategies.

In addition, stakeholders must navigate a complex supplier network spanning component manufacturers, device OEMs, and distribution partners. The shift of many procedures to outpatient and ambulatory surgical centers has introduced different purchasing frameworks and clinical requirements, influencing the types of closure mechanisms preferred by clinicians. Given this backdrop, the following sections unpack transformative shifts in clinical practice, tariff impacts that have reshaped supply chain calculus in the United States, segmentation-driven insights, regional nuances, competitor behavior, and concrete recommendations for leaders aiming to maintain or extend competitive advantage.

Critical technological, procedural, and supply chain shifts that are reshaping clinical adoption, procurement priorities, and competitive differentiation in device selection

Over the past several years, the landscape for arteriotomy closure has undergone a series of transformative shifts driven by concurrent technological, procedural, and delivery-model changes. Device technologies have evolved from traditional suture-based systems toward an increasingly diverse mix that emphasizes rapid hemostasis, reduced time to ambulation, and compatibility with percutaneous large-bore access. Complementing device innovation, clinicians have embraced procedural standardization and imaging-guided approaches that reduce variability in outcomes, which in turn affects hospital adoption curves and purchasing priorities.

Operationally, the migration of select interventions to ambulatory surgical centers and same-day discharge pathways has influenced product selection toward devices that simplify workflows and minimize the need for extended post-procedure monitoring. Regulatory emphasis on real-world evidence and post-market surveillance has raised expectations for rigorous clinical data, prompting manufacturers to invest in registries and longitudinal outcome tracking. Concurrently, supply chain resiliency has become a strategic priority after recent disruptions, motivating some organizations to diversify suppliers and source critical materials closer to manufacturing hubs. Taken together, these shifts have increased the premium on devices that combine clinical performance with clear value narratives tied to efficiency, safety, and total cost of care.

How tariff-driven cost pressures and supply chain disruptions have influenced sourcing decisions, pricing dynamics, and strategic procurement priorities through 2025

The cumulative impact of United States tariff measures enacted and adjusted through 2025 has reverberated across the arteriotomy closure device value chain, with measurable effects on component sourcing, production planning, and pricing strategies. Tariff pressures have increased the cost sensitivity for manufacturers that rely on imported raw materials and components, subsequently influencing decisions regarding inventory buffering and supplier diversification. In response, some manufacturers have accelerated localization initiatives and renegotiated supplier contracts to mitigate exposure to tariff volatility and customs delays.

Procurement teams at hospitals and ambulatory centers have faced tighter negotiations as suppliers pass through incremental costs or seek long-term purchase agreements to stabilize volumes. At the same time, the tariff environment has prompted a reexamination of supply chain risk assessments, with greater emphasis on dual sourcing, contractual flexibility, and longer lead-time planning. For product managers, the tariff landscape has created an imperative to articulate cost-to-serve and total lifecycle benefits more clearly, so that incremental procurement premiums can be justified by demonstrable reductions in post-procedural complications, shortened length of stay, or decreased device reinterventions. Ultimately, tariff-driven cost pressures have reinforced the strategic importance of supply chain transparency and proactive engagement with procurement stakeholders to maintain market access and preserve pricing power.

An integrated segmentation perspective linking mechanism, clinical setting, material composition, and distribution channels to adoption drivers and commercialization choices

Deep segmentation analysis reveals how device design, clinical setting, and material selection collectively shape adoption patterns and go-to-market strategies. Based on closure mechanism, the market encompasses clip based systems, plug based solutions, sealant based products, and suture based devices; clip based systems are differentiated further by metallic clips and polymer clips, while plug based solutions segment into collagen plug and polymer plug variants, and suture based options split into absorbable and nonabsorbable formats. These mechanistic differences influence operator choice by balancing ease of use, device profile, and compatibility with specific access sizes, and they also dictate manufacturing complexity and regulatory pathways.

Based on end use, the clinical environment spans ambulatory surgical centers, cardiac catheterization laboratories, and hospitals, with hospitals subdivided into private hospitals and public hospitals; each setting imposes distinct procurement cycles, staff competencies, and reimbursement realities. Devices intended for ambulatory surgical centers often prioritize rapid hemostasis and minimal monitoring requirements, whereas those deployed in catheterization labs must integrate with high-throughput procedural lists and operator preferences. Based on application, clinical utilization covers cardiology procedures, peripheral vascular interventions, and radiology-guided access, and these applications vary in access size, anticoagulation practices, and post-procedure care pathways, all of which dictate product specifications and training needs.

Based on material, device platforms are developed using collagen, metallic, and polymeric materials, each presenting distinct trade-offs in bioresorption, inflammatory profile, and manufacturing cost. Material choice carries implications for regulatory submissions, post-market surveillance, and differentiation in clinical evidence. Finally, based on distribution channel, devices reach end-users through direct sales forces, distributors, and online vendors; channel strategy impacts the sales model, training delivery, and after-sales service expectations. Direct sales often enable clinical training and integrated value messaging, while distributors and online vendors can expand reach but may require complementary support programs to ensure proper adoption and device utilization.

Regional nuances in payer behavior, regulatory complexity, and procedural growth that determine differentiated commercialization and evidence generation tactics

Regional dynamics continue to exert a meaningful influence on product development priorities, regulatory strategy, and commercial planning. In the Americas, health systems emphasize efficiency gains and technologies that support same-day discharge, with payers increasingly focused on outcomes and bundled payment models; this encourages devices that reduce length of stay and demonstrably lower complication rates. Across Europe, Middle East & Africa, heterogeneous regulatory frameworks and varied reimbursement environments mean market entry often requires multiple localized evidence packages and adaptive pricing strategies, while centers of excellence in major European markets drive clinical adoption that subsequently diffuses to neighboring health systems.

In Asia-Pacific, rapid procedural growth, hospital expansion, and cost-conscious procurement shape demand for scalable device platforms and streamlined training programs. Local manufacturing capabilities and regional supply chain hubs in several Asia-Pacific markets also alter sourcing calculus for global manufacturers seeking cost-effective production. Transitional shifts across these regions-such as the expansion of ambulatory care models in the Americas, regulatory convergence in parts of Europe, Middle East & Africa, and investment in interventional facilities in Asia-Pacific-underscore the need for market-specific evidence, adaptive commercialization playbooks, and flexible partnership structures to capture regional opportunities effectively.

Competitive landscape dynamics emphasizing evidence generation, targeted partnerships, and integrated service models that drive differentiation and adoption

Competitive dynamics in the arteriotomy closure arena are defined by a mix of entrenched medical device players, specialized niche manufacturers, and emerging entrants that leverage novel materials or simplified deployment techniques. Leading companies prioritize clinical evidence generation, robust post-market surveillance, and clinician training programs to reduce variability in outcomes and accelerate adoption among high-volume operators. Strategic behaviors observed across the landscape include targeted acquisitions to broaden product portfolios, partnerships with contract manufacturers to scale production capacity quickly, and investments in gather-and-analyze initiatives that aggregate real-world outcomes for regulatory and payer engagement.

Market leaders also differentiate through comprehensive services such as on-site training, proctoring, and integrated data platforms that track device performance across institutions. Meanwhile, mid-sized and smaller firms often compete on innovation speed, introducing iterative improvements in device profile, deployment simplicity, or material composition that appeal to specific clinical niches. Across the competitive set, success correlates strongly with the ability to articulate a clear value proposition that connects clinical advantages to operational efficiencies and economic outcomes valued by purchasing committees, while maintaining supply chain continuity and regulatory compliance.

High-impact operational, clinical evidence, and commercial actions that companies should implement to strengthen market position and accelerate adoption

Industry leaders should pursue a set of coordinated actions that align product, clinical, and commercial strategies to create defensible advantages. First, prioritize development and communication of robust real-world evidence and clinician-authored outcomes studies that link device performance with measurable improvements in patient throughput and complication reduction. Second, redesign supply chain architectures to reduce exposure to tariff volatility and single-source risks by qualifying alternate suppliers and exploring regional manufacturing options where feasible. Third, tailor go-to-market models to specific clinical settings by providing targeted training and support for ambulatory surgical centers, catheterization labs, and hospital systems, ensuring that each channel receives appropriate onboarding and post-implementation follow-up.

Additionally, invest in material and design optimization that reduces procedural complexity, shortens deployment time, and favors compatibility across common access sizes. Engage early with payers and hospital procurement teams to build value dossiers that translate clinical benefits into procurement-relevant economic terms. Finally, consider strategic partnership models with distributors and technology platforms to extend reach while maintaining clinical oversight, and commit to continuous post-market surveillance to support regulatory compliance and iterative product improvement. These combined actions will help organizations manage near-term headwinds while positioning them for sustainable growth as procedural pathways and care delivery models evolve.

A rigorous mixed-methods research approach combining clinician interviews, literature review, and real-world evidence triangulation to validate strategic findings

This analysis synthesizes primary and secondary research methods to ensure findings are validated across clinical, commercial, and regulatory dimensions. Primary inputs included structured interviews with interventional cardiologists, vascular surgeons, interventional radiologists, procurement leaders, and product managers, supplemented by clinician surveys focused on device selection criteria and procedural workflows. Secondary research incorporated peer-reviewed clinical literature, regulatory filings, and published professional society guidance to contextualize device performance and safety assertions. Data triangulation techniques were applied to reconcile differences across sources and highlight consistent themes.

Where possible, real-world registry data and post-market surveillance summaries were reviewed to assess longer-term outcomes and complication profiles. The methodology emphasized source transparency, cataloging interview samples and inclusion criteria to support reproducibility. Finally, limitations are acknowledged: the analysis focuses on observable trends and stakeholder perspectives rather than proprietary contractual terms, and readers should interpret anecdotal insights alongside documented clinical evidence. Despite these constraints, the research approach provides a robust foundation for strategic decision-making by combining practitioner insights with documented clinical and regulatory information.

A strategic synthesis emphasizing evidence alignment, supply chain resilience, and targeted commercialization as imperatives for sustained competitive advantage

In summary, the arteriotomy closure device environment is maturing toward solutions that deliver demonstrable clinical benefits while fitting within evolving care delivery and reimbursement models. Technological innovation, procedural shifts toward outpatient care, and supply chain pressures driven by tariff dynamics have collectively influenced product selection and commercialization strategies. Stakeholders that align evidence generation with operational value propositions and address supply chain resiliency will be best positioned to influence purchasing decisions and clinical pathways.

Decision-makers should treat this juncture as an opportunity to refine product roadmaps, strengthen relationships with clinical champions, and proactively engage payers with robust outcome data. By doing so, organizations can convert the current period of transformation into a sustained advantage, enabling safer, more efficient patient care and clearer economic value for health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Arteriotomy Closure Devices Market, by Closure Mechanism

  • 8.1. Clip Based
    • 8.1.1. Metallic Clip
    • 8.1.2. Polymer Clip
  • 8.2. Plug Based
    • 8.2.1. Collagen Plug
    • 8.2.2. Polymer Plug
  • 8.3. Sealant Based
  • 8.4. Suture Based
    • 8.4.1. Absorbable
    • 8.4.2. Non Absorbable

9. Arteriotomy Closure Devices Market, by Material

  • 9.1. Collagen
  • 9.2. Metallic
  • 9.3. Polymeric

10. Arteriotomy Closure Devices Market, by End Use

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Catheterization Laboratories
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Arteriotomy Closure Devices Market, by Application

  • 11.1. Cardiology
  • 11.2. Peripheral Vascular
  • 11.3. Radiology

12. Arteriotomy Closure Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Vendors

13. Arteriotomy Closure Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Arteriotomy Closure Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Arteriotomy Closure Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Arteriotomy Closure Devices Market

17. China Arteriotomy Closure Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Aesculap, Inc.
  • 18.7. Arstasis, Inc.
  • 18.8. Artivion, Inc.
  • 18.9. Boston Scientific Corporation
  • 18.10. Cardinal Health, Inc.
  • 18.11. CytoSorbents Corporation
  • 18.12. Fumedica AG
  • 18.13. Humacyte Global Inc.
  • 18.14. iVascular, S.L.U
  • 18.15. IVT Medical Ltd.
  • 18.16. KOAG LLC
  • 18.17. Medtronic plc
  • 18.18. Meril Life Sciences Pvt. Ltd.
  • 18.19. Merit Medical Systems, Inc.
  • 18.20. Mitralign Inc.
  • 18.21. Teleflex Incorporated
  • 18.22. Terumo Medical Corporation
  • 18.23. TOTAL Vein Solutions, LLC
  • 18.24. Transluminal Technologies Inc.
  • 18.25. Tricol Biomedical Inc.
  • 18.26. Vasorum Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC CLIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC CLIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC CLIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN PLUG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN PLUG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN PLUG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER PLUG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER PLUG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMER PLUG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SEALANT BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SEALANT BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SEALANT BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY METALLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMERIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMERIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY POLYMERIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ONLINE VENDORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ONLINE VENDORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY ONLINE VENDORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 177. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 178. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 179. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 180. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 207. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 208. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 209. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 210. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 213. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. G7 ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 217. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 218. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 219. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 220. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 222. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. NATO ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY CLIP BASED, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY PLUG BASED, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY SUTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA ARTERIOTOMY CLOSURE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)